Last reviewed · How we verify
NCT05604924
Virtual Reality Training Simulator for Cesarean Section
NA trial testing virtual reality training for cesarean section in Virtual Reality in 150 participants. Completed in 30 November 2022.
15 November 2022
Quick facts
| Lead sponsor | Seoul National University Bundang Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 150 |
| Start date | 10 September 2022 |
| Primary completion | 15 November 2022 |
| Estimated completion | 30 November 2022 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- virtual reality training for cesarean section
Conditions studied
- Virtual Reality — all drugs for Virtual Reality →
Sponsor
Seoul National University Bundang Hospital
Who can join
Eligibility, any sex, with Virtual Reality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this is to determine the effectiveness of virtual reality training simulator for cesarean section. Evaluate the effect of using VR surgery on the self-confidence and knowledge of cesarean section procedures.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Immersive virtual reality simulation training for cesarean section: a randomized controlled trial.
Kim HJ, Lee HK, Jang JY, Lee KN, et al · · 2024 · cited 9× · PMID 37939117 · DOI 10.1097/js9.0000000000000843
Verify or expand the search:
- PubMed search for NCT05604924
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Virtual Reality
Currently open trials in the same condition.
- NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
- NCT07343843 — Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes Duri · NA · recruiting
- NCT07410858 — Virtual Reality-Enhanced Parent Education in Neonatal Intensive Care · NA · recruiting
- NCT07021638 — EMMVIES : Walking Training at Home in VIrtual Reality for Children With Chronic Illnesses Impacting Physical Health · NA · recruiting
- NCT07236229 — The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis · NA · recruiting
Other Seoul National University Bundang Hospital trials
Trials by the same sponsor.
- NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
- NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
- NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05604924 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
- Last refreshed: 13 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604924.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing